Whan In Pharm Co.,Ltd. (016580.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.3x

Market Cap

KRW 193.25B

MomentumView details →

1D Return

−0.48%

YTD Return

−8.48%

RSI (14)

58.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.3x

Market Cap

KRW 193.25B

RSI (14)

58.9

MomentumView details →

1D Return

−0.48%

YTD Return

−8.48%

ProfitabilityView details →

Gross Margin

45.78%

Net Margin

7.48%

EBITDA Margin

10.87%

ROE (TTM)

4.81%

ROA (TTM)

4.24%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

+5.71%

EPS YoY

+5.20%

FCF YoY

+281.22%

Revenue CAGR 3Y

+8.66%

EPS CAGR 3Y

−18.22%

EBITDA YoY

−24.92%

EarningsView details →

EPS (Actual)

KRW 411.34

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

5.31%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.26x

Quick Ratio

2.48x

Div Yield

2.89%

Div Rate

KRW 300.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

273.47B

Net Income (TTM)

20.45B

Op. CF (TTM)

17.67B

Latest newsMore news →

No recent news for 016580.KS.

Similar companies

Hyundai Pharmaceutical Co., Ltd.004310.KS REYON Pharmaceutical Co., Ltd.102460.KS Yungjin Pharm. Co., Ltd.003520.KS AptaBio Therapeutics Inc.293780.KQ Boditech Med Inc.206640.KQ FutureChem Co.,Ltd220100.KQ Find similar companies →

Latest newsMore news →

No recent news for 016580.KS.